Infrainguinal occlusive disease is a complex problem necessitating the cooperation of both medical and surgical therapies to aid limb salvage and alleviate symptoms. Endovascular therapies are varied, with no treatment clearly outweighing the other in terms of efficacy and durability. Angioplasty for focal stenosis has gained ground as the treatment of choice when indicated. There has also been a rapid evolution in stent technology, from early stainless steel wall stents to today's drug eluting nitinol stents. In this article, we examine the literature on these new technologies and treatment options and make recommendations based on the best data available.
Selvin E. , Erlinger TPPrevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000 . Circulation. 2004;110: 738-743 .
2.
Wilson S. , Gelfand D. , Jimenez J.Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease . Vascular. 2006;14: 81-87 .
3.
Gardner AW , Poehlman ETExercise rehabilitation programs for the treatment of claudication pain: a meta-analysis . JAMA.1995;274: 975-980 .
4.
Gartenmann CH , Kirchberger I. , Herzig M. , et al. Effects of exercise training program on functional capacity and quality of life in patients with peripheral arterial occlusive disease: evaluation of a pilot project . Vasa. 2002;31: 29-34 .
5.
Tsai JC , Chan P. , Wang CH , et al. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease . J Intern Med.2002;252: 448-455 .
6.
Creasy TS , McMillan PJ , Fletcher Ewl , et al. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomized trial . Eur J Vasc Endovasc Surg.1990;4: 135-140 .
7.
Perkins JM , Collin J. , Creasy TS , et al. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective randomized trial . Eur J Vasc Endovasc Surg.1996;11: 409-413 .
8.
Johnson WC , Lee KKA comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study . J Vasc Surg.2000;31: 268-277 .
9.
Veith FJ , Gupta SK , Ascer E. , et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions . J Vasc Surg.1986 ;3: 104-114 .
10.
Standards of practice committee of the Society of Cardiovascular and interventional radiology: guidelines for percutaneous transluminal angioplasty . Radiology. 1990;177: 619-626 .
11.
Capek P. , McLean K. , Berkowitz D.Femoropopliteal angioplasty: factors influencing long-term success . Circulation. 1991;83(suppl 2): 170-180 .
12.
Cragg AH , Dake MDTreatment of peripheral vascular disease with stent-grafts . Radiology. 1997;205: 307-314 .
13.
Ahmadi R. , Schillinger M. , Maca T. , et al. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft . Radiology. 2002 ;223: 345-350 .
14.
Cejna M. , Turnher S. , Illiasch H. , et al. PTA versus Palmaz stent in femoropopliteal artery obstructions: a multicenter prospective randomized study . J Vasc Interv Radiol.2001;12: 23-31 .
15.
Zdanowski Z. , Albrechtsson U. , Lundin A. , et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study . Int Angiol.1999;18: 251-255 .
16.
Vroegindeweij D. , Vos LD , Tielbeek AV , et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiov IntervRadiol.1997;20: 420-425 .
17.
Becquemin JP , Favre JP , Marzelle J. , et al. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study . J Vasc Surg.2003;37: 487-494 .
18.
Sabeti S. , Schillinger M. , Amighi J. , et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis . Radiology. 2004; 232: 516-521 .
19.
Schillinger M. , Sabeti S. , Loewe C. , et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery . N Engl J Med.2006;354: 1879-1888 .
20.
Cho L. , Roffi M, Mukherjeed , et al. Superficial femoral artery occlusion: nitinol stents achieve better flow and reduce the need for medications than balloon angioplasty alone . J Invasive Cardiol. 2003; 15: 198-200 .
21.
Lenti M. , Cieri E. , De Rango P , et al. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent . J Vasc Surg.2007;45: 32-39 .
22.
Wiesinger B. , Beregi JP , Oliva V. , et al. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study . J Endovasc Ther.2005;12: 240-246 .
23.
Kedora J. , Hohmann S. , Garrett W.Randomized comparison of percutaneous Viabahn stent grafts vs. prosthetic femoral popliteal bypass in the treatment of superficial femoral arterial occlusive disease . J Vasc Surg.2007;45: 10-16 .
24.
Duda SH , Pusich B. , Richter G. , et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease . Circulation. 2002;106: 1505 .
25.
Duda SH , Bosiers M. , Lammer J. , et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II Trial. Soc IntervRadiol.2005;16: 331-338 .
26.
Cragg AH , De Jong SC , Barnhart WH , et al. Nitinol intravascular stent: results of preclinical evaluation . Radiology.1993;189: 775-778 .
27.
Scheinert D. , Scheinert S. , Sax J. , et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting . J Am Coll Cardiol.2005;45: 312-315 .
28.
Schlager O. , Dick P. , Sabeti S. , et al. Long-segment SFA stenting: the dark sides: in-stent restenosis, clinical deterioration and stent fractures . J Endovasc Ther.2005; 12: 676-684 .
Mewissen MWSelf-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results . Tech Vasc Interv Radiol.2004;7: 2-5 .
31.
US Food and Drug Administration, Center for Devices and Radiological Health.IntraCoil self-expanding peripheral stent-P000033. http://www.fda.gov/cdrh/pdf/p000033.html . Accessed February 24, 2007.
32.
Ruef J. , Hofmann, M. , Haase J.Initial clinical experience with the Protégé Everflex long self-expanding nitinol stent in the superficial femoral artery . J Interven Cardiol.2006;19: 544-546 .
33.
Jahnke T. , Anresen R, Muller-Hulsbeck , et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial . J Vasc Interv Radiol.2003;14: 41-51 .
